🇺🇸 Dsuvia in United States

36 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Nausea — 5 reports (13.89%)
  2. Reversal Of Opiate Activity — 5 reports (13.89%)
  3. Somnolence — 5 reports (13.89%)
  4. Drug Ineffective — 4 reports (11.11%)
  5. Craniofacial Fracture — 3 reports (8.33%)
  6. Oxygen Saturation Decreased — 3 reports (8.33%)
  7. Procedural Pain — 3 reports (8.33%)
  8. Product Prescribing Issue — 3 reports (8.33%)
  9. Vomiting — 3 reports (8.33%)
  10. Abnormal Behaviour — 2 reports (5.56%)

Source database →

Dsuvia in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Other approved in United States

Frequently asked questions

Is Dsuvia approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Dsuvia in United States?

Montefiore Medical Center is the originator. The local marketing authorisation holder may differ — check the official source linked above.